Page last updated: 2024-09-04

moxifloxacin and clindamycin

moxifloxacin has been researched along with clindamycin in 83 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (clindamycin)	Trials (clindamycin)	Recent Studies (post-2010) (clindamycin)
3,157	552	1,690	6,297	892	1,636

Research

Studies (83)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (1.20)	18.2507
2000's	37 (44.58)	29.6817
2010's	38 (45.78)	24.3611
2020's	7 (8.43)	2.80

Authors

Authors	Studies
Duewelhenke, N; Eysel, P; Krut, O	1
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S	1
Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA	1
Finegold, SM; Golan, Y; Goldstein, EJ; Gorbach, SL; Harrell, LJ; Hecht, DW; Jacobus, NV; Jenkins, SG; McDermott, LA; Pierson, C; Rihs, J; Ruthazer, R; Snydman, DR; Venezia, R; Yu, V	1
Bryk, A; Kanervo-Nordström, A; Könönen, E; Niemi, P	1
Adams, DA; Donskey, CJ; Riggs, MM	1
Ardanuy, C; Bouza, E; Calatayud, L; Cercenado, E; Fenoll, A; Liñares, J; Martín, R; Pallares, R	1
Appelbaum, PC; Clark, CL; Ednie, LM; Kosowska-Shick, K	1
Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F	1
Brémont, S; Courvalin, P; Damier-Piolle, L; Lambert, T; Magnet, S	1
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG	1
Lombardo, F; Obach, RS; Waters, NJ	1
Betriu, C; Culebras, E; Gómez, M; López, F; Picazo, JJ; Rodríguez-Avial, I	1
Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC	1
Karlowsky, JA; Laing, NM; Zhanel, GG	1
Jacobus, NV; McDermott, LA; Snydman, DR	2
Bohnert, JA; Fähnrich, E; Kern, WV; Schuster, S; Wehmeier, C	1
Denis, O; Nguyen, HA; Struelens, MJ; Theunis, A; Tulkens, PM; Van Bambeke, F; Vergison, A	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE	1
Ekambaram, R; Raghunathan, M; Raghunathan, R; Rao, SS	1
Barbut, F; Bouttier, S; Collignon, A; Denève, C; Dupuy, B; Janoir, C	1
Appelbaum, PC; Beachel, L; Clark, C; Dewasse, B; Kosowska-Shick, KM; McGhee, P; Nagai, K	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A	1
Cai, L; Gilbert, GL; Kong, F; Oftadeh, S; Xiao, M; Xu, X; Zhou, F	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR	1
Ardanuy, C; Brito-Avô, A; Gonçalo-Marques, J; Liñares, J; Morais, A; Pires, R; Rolo, D; Santos-Sanches, I	1
Chong, Y; Jeong, SH; Kim, MS; Lee, K; Lee, Y; Park, Y; Yong, D	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Edlund, C; Nord, CE; Sabouri, S	1
Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A	1
Behra-Miellet, J; Dubreuil, L; Jumas-Bilak, E	1
Eisenblätter, M; Hahn, H; Ignatius, R; Jabbusch, M; Wagner, J; Wendt, C	1
Choo, CM; Lim, T; Lim, YS; Ngan, CC; Toh, GL	1
Eick, S; Pfister, W; Seltmann, T	1
Chuah, SK; Gollapudi, S; Thadepalli, H	1
Eick, S; Pfister, W	1
Ardanza-Trevijano, B; Canut, A; Isla, A; Labora, A; Pedraz, JL; Rodríguez-Gascón, A; Solinís, MA	1
Almela, M; Jurado, A; Marco, F; Mensa, J; Ortega, M; Soriano, A	1
Bolduc, DL; Brook, I; Camp-Hyde, TD; Elliott, TB; Foriska, MA; Germana, A; Giraldo, DE; Jackson, WE; Ledney, GD; Shoemaker, MO; Thakar, JH	1
Kolokotronis, AE; Stefanopoulos, PK	1
Alvarez Fernández, M; Diz Dios, P; Fernández Feijoo, J; Limeres Posse, J; Medina Henríquez, J; Tomás Carmona, I	1
Haggerty, CL; Ness, RB	1
Bélanger, M; LeCorn, DW; Progulske-Fox, A; Rojas, MF; Vertucci, FJ	1
Alvarez, M; Diz, P; Limeres, J; Potel, C; Tomás, I; Tomás, M; Velasco, D	1
Ardila, CM; Granada, MI; Guzmán, IC	1
Banaszkiewicz, A; Młynarczyk, G; Obuch-Woszczatyński, P; Pituch, H; Radzikowski, A; Wultańska, D	1
Böger, RH; Cachovan, G; Giersdorf, I; Haddad, M; Hallier, O; Platzer, U; Schön, G; Sobottka, I; Streichert, T; Wegscheider, K	1
Appelbaum, PC; Glupczynski, Y; Kosowska-Shick, K; Lemaire, S; Tulkens, PM; Van Bambeke, F	1
Barbanti, F; Mastrantonio, P; Spigaglia, P	1
Balzer, L; Böger, RH; Cachovan, G; Giersdorf, I; Haddad, M; Hallier, O; Platzer, U; Sobottka, I; Streichert, T; Wegscheider, K	1
Jacobs, F; Kubiak, J; Schaller, M; Stroelin, A	1
Persing, DH; Tenover, FC; Tickler, IA	1
Kang, JO; Kim, J; Pai, H; Seo, MR	1
Asano, K; Betsuyaku, T; Fujiwara, H; Hasegawa, N; Miyata, J; Miyazaki, M; Naoki, K; Ohkusu, K; Sayama, K; Tasaka, S; Yoshida, S	1
Blessmann, M; Cachovan, G; Heiland, M; Platzer, U; Rother, U; Schön, G; Sobottka, I; Stürenburg, E	1
Al-Ahmad, A; Ameen, H; Anderson, AC; Hellwig, E; Karygianni, L; Pelz, K; Spitzmüller, B; Wittmer, A	1
Goering, RV; Lynn, AN; Persing, DH; Tenover, FC; Tickler, IA; Whitmore, JD	1
Hegarty, JP; Jayarao, BM; Lumadue, J; Stewart, DB; Varshney, JB; Venkitanarayanan, K; Very, KJ; Williams, JL	1
Hussain, T; Liaqat, F; Muhammad, J; Nazir, J; Rabbani, M; Shaheen, AY; Sheikh, AA	1
Forbes, BA; Gerding, DN; Goldstein, EJ; Jacobus, NV; Jenkins, SG; Johnson, S; McDermott, LA; Mirrett, S; Patel, R; Snydman, DR; Stone, S; Thorpe, C	1
Bettoli, V; Join-Lambert, O; Nassif, A	1
del Mar Gamboa-Coronado, M; López-Ureña, D; Montoya-Ramírez, M; Quesada-Gómez, C; Rodríguez, C; Rodríguez-Cavallini, E; Somogyi, T	1
Casey, M; Igawa, G; Koike, R; Moriya, K; Nukui, Y; Okugawa, S; Saito, R; Sawabe, E; Tohda, S	1
Barbanti, F; Spigaglia, P	1
Kriz, Z; Krutova, M; Kubicek, L; Kuijper, E; Matejkova, J; Nyc, O; Ruzicka, F; Tejkalova, R	1
Duarte, R; Macedo, R; Mendes-Bastos, P	1
Contreras-Ramire, AA; Garcia-Cortes, JO; Loyola-Leyva, A; Loyola-Rodriguez, JP; Medina-Solis, CE; Ponce-Diaz, ME; Serena-Gomez, E	1
Chen, YB; Fang, YH; Gu, SL; Li, LJ; Lv, T; Shen, P; Tang, LL	1
Akgul, O; Jean-Pierre, H; Justesen, US; Kulekci, G; Morris, T; Nagy, E; Soyletir, G; Ulger Toprak, N; Urban, E; Veloo, ACM; Wybo, I	1
Andremont, A; Burdet, C; Corbel, T; de Gunzburg, J; Ferreira, S; Hugon, P; Mentré, F; Nguyen, TT; Pulse, M; Sablier-Gallis, F; Saint-Lu, N; Sayah-Jeanne, S; Weiss, W	1
Lu, B; Xiang, L	1
Macía, M; Navarro, D; Romay, AB; Trastoy, R; Treviño, M; Veiga, E	1
Jane, F; Jon J, V; Mark H, W	1
Adamczyk, M; Albrecht, V; Anderson, KF; Campbell, D; Elkins, CA; Gargis, AS; Guh, AY; Halpin, AL; Karlsson, M; Kent, AG; Korhonen, LC; Lutgring, JD; McAllister, G; McDonald, LC; McKay, SL; Paulick, AL; Rasheed, JK; Vlachos, N	1
Li, J; Li, N; Liu, B; Lü, X; Wang, H; Zhang, Y	1
Kim, B; Kim, J; Pai, H	1
Attin, T; Bensland, S; Eick, S; Karygianni, L; Kulik, EM; Thurnheer, T	1
Amouzou, Y; Cameron, DR; Carton, T; Chaves, RL; De Martino, A; Kühn, J; Le Fresne-Languille, S; Le Vacon, F; Leuillet, S; Nicolas-Metral, V; Nowakowska, J; Vuagniaux, G; Wittke, F	1
Cheng, VC; Chow, KH; Fang, H; Ho, PL; Li, X; Tong, MK; Yan, MK	1

Reviews

6 review(s) available for moxifloxacin and clindamycin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology]. Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23, Issue:3 Topics: Algorithms; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoroquinolones; Fusobacterium nucleatum; Humans; Microbial Sensitivity Tests; Mouth Diseases; Moxifloxacin; Peptostreptococcus; Periodontitis; Porphyromonas gingivalis; Prevotella intermedia; Quinolines; Time Factors; Viridans Streptococci	2005
Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Apr-01, Volume: 44, Issue:7 Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Female; Fluoroquinolones; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pelvic Inflammatory Disease; Quinolines; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Treatment Outcome	2007
Bacillus cereus necrotizing pneumonia in a patient with nephrotic syndrome. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Aza Compounds; Bacillus cereus; Biopsy, Needle; Bronchoalveolar Lavage Fluid; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Immunohistochemistry; Male; Meropenem; Moxifloxacin; Necrosis; Nephrotic Syndrome; Pneumonia, Bacterial; Quinolines; Radiography, Thoracic; Risk Assessment; Severity of Illness Index; Thienamycins; Tomography, X-Ray Computed; Treatment Outcome	2013
Antibiotic Treatment of Hidradenitis Suppurativa. Dermatologic clinics, 2016, Volume: 34, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Clindamycin; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Imipenem; Maintenance Chemotherapy; Metronidazole; Moxifloxacin; Remission Induction; Rifampin	2016
Infection due to Mycoplasma hominis after left hip replacement: case report and literature review. BMC infectious diseases, 2019, Jan-14, Volume: 19, Issue:1 Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Clindamycin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Postoperative Complications	2019

Trials

4 trial(s) available for moxifloxacin and clindamycin

Article	Year
Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:9 Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteremia; Clindamycin; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Prospective Studies; Quinolines; Streptococcal Infections; Streptococcus; Tooth Extraction	2006
Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:3 Topics: Abscess; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Clindamycin; Double-Blind Method; Female; Fluoroquinolones; Gingivitis; Humans; Male; Middle Aged; Moxifloxacin; Neutrophil Infiltration; Quinolines; Young Adult	2011
Microbiological analysis of a prospective, randomized, double-blind trial comparing moxifloxacin and clindamycin in the treatment of odontogenic infiltrates and abscesses. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Clindamycin; Culture Media; Double-Blind Method; Female; Fluoroquinolones; Germany; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Outpatients; Penicillins; Periodontal Abscess; Prospective Studies; Quinolines	2012
Radiography-based score indicative for the pathogenicity of bacteria in odontogenic infections. Acta odontologica Scandinavica, 2014, Volume: 72, Issue:7 Topics: Abscess; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacteroidaceae Infections; Clindamycin; Double-Blind Method; Female; Fluoroquinolones; Fusobacterium Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Periapical Abscess; Periodontal Abscess; Prospective Studies; Radiography; Staphylococcal Infections; Streptococcal Infections; Tooth Diseases; Virulence; Young Adult	2014

Other Studies

73 other study(ies) available for moxifloxacin and clindamycin

Article	Year
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1 Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors	2007
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen	2007
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles	2007
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5 Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Time Factors; United States	2007
Antimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteremia; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Peptostreptococcus; Species Specificity	2007
Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic clostridium difficile strains in the cecal contents of mice. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8 Topics: Anaerobiosis; Animals; Anti-Infective Agents; Bacterial Toxins; Cecum; Clostridioides difficile; Disease Models, Animal; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Humans; Mice; Microbial Sensitivity Tests	2007
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9 Topics: Anti-Bacterial Agents; Clone Cells; Drug Resistance, Multiple, Bacterial; Electrophoresis, Polyacrylamide Gel; Erythromycin; Genes, Bacterial; Microbial Sensitivity Tests; Phenotype; Pneumococcal Infections; Serotyping; Spain; Streptococcus pneumoniae; Tetracycline Resistance	2007
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Imipenem; Ketolides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae	2007
Antimicrobial susceptibilities and clinical sources of Dialister species. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae	2007
AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Multigene Family; Sequence Analysis, DNA; Substrate Specificity	2008
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Spain; Species Specificity; Time Factors	2008
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan	2008
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests	2008
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests	2008
Site-directed mutagenesis reveals amino acid residues in the Escherichia coli RND efflux pump AcrB that confer macrolide resistance. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Macrolides; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Mutagenesis, Site-Directed; Sequence Homology, Amino Acid	2009
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4 Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Dose-Response Relationship, Drug; Fusidic Acid; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Oxacillin; Phenotype; Protein Binding; Staphylococcus aureus; Thymidine	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests	2009
In vitro activity of a new quinoline derivative, ER-2, against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycoplasma hominis; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Quinolines	2009
Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Ampicillin; Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Clindamycin; Clostridioides difficile; Cysteine Endopeptidases; DNA Gyrase; Fluoroquinolones; Frameshift Mutation; Immunoblotting; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Polymerase Chain Reaction; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; Sequence Deletion	2009
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Macrolides; Microbial Sensitivity Tests; Penicillin G; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles	2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline	2010
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; Child, Preschool; DNA Transposable Elements; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Macrolides; Microbial Sensitivity Tests; New South Wales; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States	2010
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Amino Acid Substitution; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Carrier Proteins; Child; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Molecular Epidemiology; Norfloxacin; Point Mutation; Portugal; Streptococcal Infections; Streptococcus pyogenes	2010
Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Positive Cocci; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Republic of Korea	2010
Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:3 Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Cefoxitin; Cephamycins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Thienamycins	1998
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates. International journal of antimicrobial agents, 2002, Volume: 19, Issue:2 Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma; Quinolines; Streptococcus; Teicoplanin; Thienamycins; Vancomycin	2002
Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams. International journal of antimicrobial agents, 2002, Volume: 20, Issue:5 Topics: Anaerobiosis; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; beta-Lactams; Ciprofloxacin; Clindamycin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines	2002
Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Campylobacter jejuni; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Germany; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Tetracycline	2003
Susceptibility testing of Singapore strains of Mycoplasma hominis to tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin, and azithromycin by the Etest method. Diagnostic microbiology and infectious disease, 2004, Volume: 48, Issue:3 Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma hominis; Quinolines; Sampling Studies; Sensitivity and Specificity; Singapore; Tetracycline	2004
Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study. Journal of clinical periodontology, 2004, Volume: 31, Issue:5 Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Biofilms; Clindamycin; Doxycycline; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Moxifloxacin; Porphyromonas gingivalis; Quinolines; Saliva, Artificial; Streptococcus constellatus; Time Factors	2004
Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice. Chemotherapy, 2004, Volume: 50, Issue:2 Topics: Abdominal Abscess; Animals; Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Disease Models, Animal; Fluoroquinolones; Injections, Subcutaneous; Levofloxacin; Male; Metronidazole; Mice; Moxifloxacin; Ofloxacin; Quinolines	2004
Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study. Journal of periodontology, 2004, Volume: 75, Issue:10 Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clindamycin; Colony Count, Microbial; Doxycycline; Fluoroquinolones; Humans; Intracellular Space; KB Cells; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Periodontitis; Periodontium; Porphyromonas gingivalis; Quinolines; Streptococcus constellatus; Time Factors	2004
[In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2005, Volume: 18, Issue:2 Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Clindamycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Oxazolidinones; Quinolines; Rifampin; Staphylococcus aureus; Staphylococcus epidermidis	2005
Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:6 Topics: Administration, Oral; Animals; Anthrax; Anti-Bacterial Agents; Aza Compounds; Bacillus anthracis; Blood; Ciprofloxacin; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Female; Fluoroquinolones; Gamma Rays; Injections, Subcutaneous; Liver; Lung; Mice; Moxifloxacin; Quinolines; Radiation Injuries, Experimental; Survival Analysis	2005
Controversies in antibiotic choices for odontogenic infections. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2006, Volume: 101, Issue:6 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Anaerobic; Bacterial Infections; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Focal Infection, Dental; Humans; Moxifloxacin; Quinolines; Spain; Streptococcal Infections; Viridans Streptococci	2006
In vitro activity of amoxicillin, clindamycin, doxycycline, metronidazole, and moxifloxacin against oral Actinomyces. Journal of endodontics, 2007, Volume: 33, Issue:5 Topics: Actinomyces; Actinomycosis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clindamycin; Doxycycline; Fluoroquinolones; Humans; Metronidazole; Moxifloxacin; Periapical Periodontitis; Quinolines	2007
Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials. Oral microbiology and immunology, 2007, Volume: 22, Issue:5 Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Blood; Clindamycin; Culture Media; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Anaerobic Bacteria; Hemin; Humans; Ketolides; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Penicillin Resistance; Periodontitis; Quinolines; Saliva; Vitamin K	2007
Antibiotic resistance of subgingival species in chronic periodontitis patients. Journal of periodontal research, 2010, Volume: 45, Issue:4 Topics: Adult; Aged; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Infective Agents; Aza Compounds; Bacteriological Techniques; beta-Lactam Resistance; Chronic Periodontitis; Clindamycin; Colombia; Dental Plaque; Drug Resistance, Bacterial; Female; Fluoroquinolones; Fusobacterium nucleatum; Gingival Hemorrhage; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Periodontal Attachment Loss; Periodontal Pocket; Porphyromonas gingivalis; Prevotella; Quinolines	2010
[Prevalence of Clostridium difficile in the gastrointestinal tract of hospitalized children under two years of age]. Medycyna doswiadczalna i mikrobiologia, 2010, Volume: 62, Issue:1 Topics: Aza Compounds; Ciprofloxacin; Clindamycin; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Female; Fluoroquinolones; Gastrointestinal Tract; Gatifloxacin; Genotype; Humans; Infant; Infant, Newborn; Male; Metronidazole; Moxifloxacin; Phenotype; Quinolines; Species Specificity; Vancomycin	2010
In vitro activity of ceftaroline against a broad spectrum of recent clinical anaerobic isolates. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Anaerobic; Ceftaroline; Ceftriaxone; Cephalosporins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Quinolines; Tigecycline	2011
Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Cell Line; Clindamycin; Community-Acquired Infections; Fluoroquinolones; Humans; Linezolid; Macrophages; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Oxazolidinones; Phagocytosis; Quinolines; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination	2011
Multidrug resistance in European Clostridium difficile clinical isolates. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:10 Topics: Anti-Bacterial Agents; Aza Compounds; Clindamycin; Clostridioides difficile; Clostridium Infections; DNA Transposable Elements; DNA, Ribosomal; Drug Resistance, Multiple, Bacterial; Erythromycin; Europe; Fluoroquinolones; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Moxifloxacin; Quinolines; Ribosomal Proteins; Rifampin; RNA, Ribosomal, 23S; Tetracycline	2011
Recurrent erysipelas secondary to a late prosthetic femoropopliteal bypass infection. Acta dermato-venereologica, 2013, Volume: 93, Issue:1 Topics: Aged; Anti-Infective Agents; Aza Compounds; Blood Vessel Prosthesis; Clindamycin; Coated Materials, Biocompatible; Erysipelas; Femoral Artery; Fluoroquinolones; Humans; Male; Moxifloxacin; Penicillin G; Peripheral Vascular Diseases; Popliteal Artery; Prosthesis-Related Infections; Quinolines; Recurrence; Reoperation	2013
Antimicrobial-resistant strains of Clostridium difficile from North America. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6 Topics: Anti-Bacterial Agents; Aza Compounds; Clindamycin; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; North America; Quinolines; Ribotyping; Rifampin	2012
Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections. BMC infectious diseases, 2012, May-09, Volume: 12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Bacterial Toxins; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Microbial; Enterotoxins; Feces; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Risk Factors; Severity of Illness Index; Treatment Outcome	2012
Antibiotic resistance and capacity for biofilm formation of different bacteria isolated from endodontic infections associated with root-filled teeth. Journal of endodontics, 2014, Volume: 40, Issue:2 Topics: Actinomyces; Actinomyces viscosus; Amoxicillin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clindamycin; Dental Pulp Diseases; Doxycycline; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Fosfomycin; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Limosilactobacillus fermentum; Moxifloxacin; Penicillin G; Penicillin Resistance; Prevotella; Propionibacterium; Rifampin; Streptococcus mutans; Tetracycline Resistance; Tooth, Nonvital; Vancomycin Resistance	2014
Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:7 Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Feces; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ribotyping; United States; Vancomycin; Vancomycin Resistance	2014
Characterization of Clostridium difficile isolates from human fecal samples and retail meat from Pennsylvania. Foodborne pathogens and disease, 2014, Volume: 11, Issue:10 Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cattle; Chickens; Clindamycin; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Feces; Fluoroquinolones; Gene Deletion; Genes, Bacterial; Genotype; Humans; Meat; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Pennsylvania; Phenotype; Repressor Proteins; Ribotyping; Swine; Vancomycin	2014
Report-Isolation identification and control of vancomycin resistant Staphylococcus aureus. Pakistan journal of pharmaceutical sciences, 2015, Volume: 28, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Cinnamomum zeylanicum; Clindamycin; Curcuma; Fluoroquinolones; Garlic; Humans; Linezolid; Mentha; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Nigella sativa; Oxazolidinones; Pakistan; Plant Extracts; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Syzygium; Vancomycin Resistance; Wound Infection	2015
U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Fluoroquinolones; Genes, Bacterial; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multiplex Polymerase Chain Reaction; Prohibitins; Sentinel Surveillance; United States; Vancomycin	2015
Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks. Emerging microbes & infections, 2016, May-11, Volume: 5 Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Communicable Diseases, Emerging; Costa Rica; Cross Infection; Diarrhea; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genes, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Ribotyping; Time Factors; Vancomycin	2016
Comparison of agar dilution and broth microdilution methods for Clostridium difficile antimicrobial susceptibility testing. Journal of global antimicrobial resistance, 2016, Volume: 7 Topics: Agar; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Fluoroquinolones; Japan; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Vancomycin	2016
Characterization of Clostridium difficile PCR-ribotype 018: A problematic emerging type. Anaerobe, 2016, Volume: 42 Topics: Anti-Bacterial Agents; Antibiosis; Bacterial Adhesion; Bacterial Toxins; Caco-2 Cells; Clindamycin; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Erythromycin; Fluoroquinolones; Hospitals; Humans; Italy; Moxifloxacin; Ribotyping; Rifampin; Virulence	2016
Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:5 Topics: Aged; Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Clostridioides difficile; Clostridium Infections; Czech Republic; DNA Gyrase; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Capillary; Female; Fluoroquinolones; Gene Expression; Humans; Male; Methyltransferases; Metronidazole; Microbial Sensitivity Tests; Minisatellite Repeats; Moxifloxacin; Multilocus Sequence Typing; Retrospective Studies; Ribotyping; Tertiary Care Centers; Vancomycin	2017
Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis? The British journal of dermatology, 2017, Volume: 177, Issue:4 Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Clindamycin; Contraindications, Drug; Drug Administration Schedule; Drug Therapy, Combination; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant	2017
Determination and identification of antibiotic-resistant oral streptococci isolated from active dental infections in adults. Acta odontologica Scandinavica, 2018, Volume: 76, Issue:4 Topics: Adult; Anti-Bacterial Agents; Clindamycin; Cross-Sectional Studies; Dental Plaque; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Streptococcus; Streptococcus mutans; Tooth Diseases	2018
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China. Journal of medical microbiology, 2018, Volume: 67, Issue:1 Topics: Anti-Infective Agents; Bacterial Proteins; China; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Moxifloxacin; Tertiary Care Centers; Vancomycin	2018
A multicenter survey of antimicrobial susceptibility of Prevotella species as determined by Etest methodology. Anaerobe, 2018, Volume: 52 Topics: Ampicillin; Anti-Bacterial Agents; Bacteroidaceae Infections; Clindamycin; Disk Diffusion Antimicrobial Tests; Fluoroquinolones; Humans; Kuwait; Meropenem; Metronidazole; Moxifloxacin; Prevotella; Sulbactam; Thienamycins; Turkey	2018
Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:10 Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Cricetinae; Dysbiosis; Gastrointestinal Microbiome; Male; Mesocricetus; Moxifloxacin	2018
Prevalence of genital Mycoplasma and response to eradication treatment in patients undergoing assisted reproductive techniques. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2019, Volume: 32, Issue:4 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Clindamycin; Doxycycline; Embryo Implantation; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Prevalence; Real-Time Polymerase Chain Reaction; Reproductive Techniques, Assisted; Semen Analysis; Sex Factors; Treatment Outcome; Ureaplasma Infections; Ureaplasma urealyticum; Young Adult	2019
Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities. Anaerobe, 2021, Volume: 70 Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; United Kingdom; Vancomycin	2021
Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 03-04, Volume: 76, Issue:5 Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Genomics; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ribotyping; United States; Vancomycin	2023
Antibiotic susceptibility and biofilm-forming ability of Veillonella strains. Anaerobe, 2022, Volume: 78 Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Cefoxitin; Clindamycin; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin; Tazobactam; Tetracyclines; Vancomycin; Veillonella	2022
Diversity of binary toxin positive Clostridioides difficile in Korea. Scientific reports, 2023, 01-11, Volume: 13, Issue:1 Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Republic of Korea; Toxins, Biological	2023
Antibiotic Resistance among Fusobacterium, Capnocytophaga, and Leptotrichia Species of the Oral Cavity. Oral health & preventive dentistry, 2023, Mar-15, Volume: 21, Issue:1 Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Capnocytophaga; Ciprofloxacin; Clindamycin; Doxycycline; Drug Resistance, Bacterial; Fusobacterium; Humans; Leptothrix; Leptotrichia; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Periodontal Diseases	2023
Evaluation of the microbiota-sparing properties of the anti-staphylococcal antibiotic afabicin. The Journal of antimicrobial chemotherapy, 2023, 08-02, Volume: 78, Issue:8 Topics: Animals; Anti-Bacterial Agents; Clindamycin; Humans; Linezolid; Mice; Microbiota; Moxifloxacin; Staphylococcus	2023
Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong, 2020-2021. Anaerobe, 2023, Volume: 82 Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Clindamycin; Hong Kong; Imipenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Retrospective Studies; RNA, Ribosomal, 16S	2023